ABSTRACT
La intoxicación humana por rodenticidas anticoagulantes de acción prolongada, conocidos como superwarfarinas, provoca coagulopatía de prolongado manejo. Presentamos el caso de un hombre de 42 años que ingirió una dosis tóxica de rodenticida en un intento suicida, evolucionando con epistaxis, INR de 11,6 y necesidad de hospitalización. Durante 7 días se realizaron controles seriados de pruebas de coagulación, con optimización de diferentes dosis de suplementación de Vitamina K. El caso destaca la potencia y vida media prolongada (aproximadamente 6 semanas) de este tipo de anticoagulantes, hecho que requiere un control clínico regular y una adherencia al tratamiento satisfactoria.
Human intoxication by long-acting anticoagulant rodenticides, known as superwarfarins, causes coagulopathy that is difficult to manage. We present the case of a 42-year-old man who ingested a toxic dose of rodenticide in a suicide attempt, evolving with epistaxis, INR of 11.6, and needing hospitalization. For seven days, serial controls of coagulation tests were carried out, with optimization of different doses of Vitamin K supplementation. The case highlights this type of anticoagulant's potency and prolonged half-life (approximately six weeks), which requires regular clinical control and satisfactory treatment adherence.
Subject(s)
Humans , Male , Adult , Rodenticides/poisoning , Suicide, Attempted , Anticoagulants/poisoning , Vitamin K/therapeutic use , 4-Hydroxycoumarins/poisoningABSTRACT
Human intoxication by long-acting anticoagulant rodenticides, known as superwarfarins, causes coagulopathy that is difficult to manage. We present the case of a 42-year-old man who ingested a toxic dose of rodenticide in a suicide attempt, evolving with epistaxis, INR of 11.6, and needing hospitalization. For seven days, serial controls of coagulation tests were carried out, with optimization of different doses of Vitamin K supplementation. The case highlights this type of anticoagulant's potency and prolonged half-life (approximately six weeks), which requires regular clinical control and satisfactory treatment adherence.
Subject(s)
Anticoagulants , Rodenticides , Suicide, Attempted , Humans , Male , Adult , Rodenticides/poisoning , Anticoagulants/poisoning , 4-Hydroxycoumarins/poisoning , Vitamin K/therapeutic useABSTRACT
La enoxaparina es una heparina de bajo peso molecular utilizada en el período neonatal. Requiere menor monitoreo que la heparina estándar o no fraccionada, si bien es escaso el conocimiento actual acerca de su dosis y de los niveles terapéuticos en los neonatos. Además, existe una información muy limitada respecto del manejo de su sobredosificación en este grupo de edad. Se presenta el primer caso publicado en castellano de un neonato que recibió una dosis de enoxaparina diez veces superior a la terapéutica de forma accidental y en el que se administró una dosis aislada de protamina para revertir su efecto.
Enoxaparin is a low molecular weight heparin used in the neonatal period. It requires less monitoring than standard or unfractionated heparin, although current knowledge about its dose and therapeutic levels in neonates is scarce. In addition, there is very limited information about the management of overdose in this age group. We present the first case published in Spanish of a neonate who accidentally received a dose of enoxaparin ten times higher than the therapeutic one and an isolated dose of protamine to reverse its effect.
Subject(s)
Humans , Male , Infant, Newborn , Protamines/administration & dosage , Enoxaparin/poisoning , Heparin Antagonists/administration & dosage , Anticoagulants/poisoning , Drug Overdose , Medication ErrorsABSTRACT
Enoxaparin is a low molecular weight heparin used in the neonatal period. It requires less monitoring than standard or unfractionated heparin, although current knowledge about its dose and therapeutic levels in neonates is scarce. In addition, there is very limited information about the management of overdose in this age group. We present the first case published in Spanish of a neonate who accidentally received a dose of enoxaparin ten times higher than the therapeutic one and an isolated dose of protamine to reverse its effect.
La enoxaparina es una heparina de bajo peso molecular utilizada en el período neonatal. Requiere menor monitoreo que la heparina estándar o no fraccionada, si bien es escaso el conocimiento actual acerca de su dosis y de los niveles terapéuticos en los neonatos. Además, existe una información muy limitada respecto del manejo de su sobredosificación en este grupo de edad. Se presenta el primer caso publicado en castellano de un neonato que recibió una dosis de enoxaparina diez veces superior a la terapéutica de forma accidental y en el que se administró una dosis aislada de protamina para revertir su efecto.
Subject(s)
Anticoagulants/poisoning , Enoxaparin/poisoning , Heparin Antagonists/administration & dosage , Protamines/administration & dosage , Drug Overdose , Humans , Infant, Newborn , Male , Medication ErrorsABSTRACT
Um cão adulto, fêmea, SRD e 5,0 kg foi atendido no Hospital de Clínicas Veterinárias da Universidade Federal do Rio Grande do Sul com sinais de choque. A anamnese não revelou nenhuma informação consistente. No exame clínico, o paciente apresentava estado de estupor, midríase, hipotermia (36,5oC), bradicardia (50 b.p.m), cianose e presença de hemorragia contínua em região digital. O animal foi imediatamente colocado em oxigênio e submetido à fluidoterapia intensiva com fluido cristalóide (90ml/kg/hora).
Subject(s)
Female , Animals , Adult , Dogs , Shock, Hemorrhagic/veterinary , Coumarins/adverse effects , Hypovolemia/veterinary , Rodenticides/poisoning , Anticoagulants/adverse effects , Anticoagulants/poisoningABSTRACT
Um cão adulto, fêmea, SRD e 5,0 kg foi atendido no Hospital de Clínicas Veterinárias da Universidade Federal do Rio Grande do Sul com sinais de choque. A anamnese não revelou nenhuma informação consistente. No exame clínico, o paciente apresentava estado de estupor, midríase, hipotermia (36,5oC), bradicardia (50 b.p.m), cianose e presença de hemorragia contínua em região digital. O animal foi imediatamente colocado em oxigênio e submetido à fluidoterapia intensiva com fluido cristalóide (90ml/kg/hora).(AU)
Subject(s)
Animals , Female , Adult , Dogs , Coumarins/adverse effects , Rodenticides/poisoning , Shock, Hemorrhagic/veterinary , Hypovolemia/veterinary , Anticoagulants/adverse effects , Anticoagulants/poisoningABSTRACT
New portable devices for the measurement of the prothrombin time and the international normalized ratio (INR) from capillary blood samples have demonstrated to have good correlation with classic laboratory methods in multiple clinical settings. In this study, we evaluated the performance of the point-of-care device CoaguChek XS (CoaguChek XS; Roche Diagnostics, Basel, Switzerland), comparing the INR results with the standard laboratory method (automatic coagulometer) in an outpatient anticoagulation clinic. Results were compared by linear regression and Bland-Altman plot. Two hundred paired results were collected from 170 patients in a period of 90 days. The main indications for anticoagulation were prophylaxis of venous thromboembolic events, atrial fibrillation and prosthetic heart valves. Mean INR results obtained with the portable device and with the standard laboratory method were 2.22â±â0.70 and 2.30â±â0.77, respectively. The proportion of patients with supratherapeutic INRs was 13.5%. The CoaguChek XS monitor tended to underestimate the INR on average by 0.08âU. The correlation coefficient (R) between the two methods was 0.91 (Pâ<â0.0001). The CoaguChek XS device is suitable for INR monitoring in patients in outpatient oral anticoagulation clinics.
Subject(s)
Point-of-Care Systems , Prothrombin Time/methods , Adolescent , Adult , Aged , Aged, 80 and over , Anticoagulants/administration & dosage , Anticoagulants/poisoning , Drug Overdose , Humans , International Normalized Ratio/instrumentation , International Normalized Ratio/methods , Middle Aged , Prothrombin Time/instrumentation , Warfarin/administration & dosage , Warfarin/poisoning , Young AdultABSTRACT
The case of a 46-year-old woman who survived after a brodifacoum poisoning is presented. The patient was admitted due to a severe coagulopathy. Initial prothrombin time and activated partial thromboplastin time were both greater than 110 seconds and the patient suffered severe gastric and pulmonary hemorrhage requiring fresh frozen plasma transfusion and parenteral phytonadione administration (up to 100 mg per day). Serum brodifacoum levels were determined by HPLC during seven months. Five days after admission, serum brodifacoum level was 1302 ng/ml. Serum brodifacoum levels decreased till day 209 when became not detectable. Brodifacoum elimination showed a first order kinetic and a 56-day half-life. Investigation of superwarfarin should be considered in any patient with vitamin K dependent coagulation disorder. It would be also useful to obtain periodic brodifacoum levels and build the corresponding elimination curve to help direct phytonadione therapy in poisoned patients.
Subject(s)
4-Hydroxycoumarins/poisoning , Anticoagulants/poisoning , Rodenticides/poisoning , 4-Hydroxycoumarins/blood , 4-Hydroxycoumarins/pharmacokinetics , Anticoagulants/blood , Anticoagulants/pharmacokinetics , Female , Hemorrhage/blood , Hemorrhage/chemically induced , Humans , Lung Diseases/blood , Lung Diseases/chemically induced , Middle Aged , Prothrombin Time , Rodenticides/blood , Rodenticides/pharmacokinetics , Stomach Diseases/blood , Stomach Diseases/chemically induced , Suicide, AttemptedABSTRACT
We report a 22 years old male, admitted to the emergency room due to a life threatening coagulation disorder, with prothrombin times fluctuation between 5 and 37% and very low activity of factors II, VII, IX and X. In the month prior to the admission, the patient had used the rodenticide difethialone, without any precaution to avoid accidental exposure. The patient was maintained with fresh frozen plasma until oral vitamin K1 was obtained. This medication corrected the coagulation disorder.